PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $456 | -23.4% | 14,868 | 0.0% | 0.01% | -16.7% |
Q2 2023 | $595 | +3.7% | 14,868 | +5.7% | 0.01% | 0.0% |
Q1 2023 | $574 | -52.9% | 14,063 | -55.5% | 0.01% | -53.8% |
Q4 2022 | $1,219 | -99.9% | 31,574 | +3.7% | 0.01% | -31.6% |
Q3 2022 | $1,619,000 | -23.2% | 30,439 | +10.2% | 0.02% | -9.5% |
Q1 2022 | $2,107,000 | +189.4% | 27,616 | +128.2% | 0.02% | +250.0% |
Q4 2021 | $728,000 | +7.4% | 12,100 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $678,000 | -7.6% | 12,100 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $734,000 | -13.4% | 12,100 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $848,000 | +17.1% | 12,100 | 0.0% | 0.01% | +14.3% |
Q4 2020 | $724,000 | -0.4% | 12,100 | 0.0% | 0.01% | -12.5% |
Q3 2020 | $727,000 | +14.5% | 12,100 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $635,000 | +56.4% | 12,100 | 0.0% | 0.01% | +33.3% |
Q1 2020 | $406,000 | -29.4% | 12,100 | -4.7% | 0.01% | 0.0% |
Q4 2019 | $575,000 | – | 12,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |